Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.23 +0.28 (+1.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Other Non-Current Liabilities (2020 - 2021)

Updated

Cullinan Therapeutics (CGEM) posted Other Non-Current Liabilities of $65,000 for Q4 2021, down 12.2% from $74,000 a year earlier and down 3.0% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends

Since Q4 2020, Cullinan Therapeutics has reported Other Non-Current Liabilities for 5 quarters.

  • In prior years, Cullinan Therapeutics' Other Non-Current Liabilities was $74,000 in FY2020.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $67,000 (Q3 2021), $70,000 (Q2 2021) and $73,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 65,000.00
Sep 30, 2021 67,000.00
Jun 30, 2021 70,000.00
Mar 31, 2021 73,000.00
Dec 31, 2020 74,000.00
API Access

Cullinan Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CGEM&period=max&api_key=YOUR_API_KEY